Clinical trials
Recruiting Cardiomyopathies trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imperial College London | 3 |
| Rocket Pharmaceuticals Inc. | 2 |
| Alnylam Pharmaceuticals | 1 |
| Barts & The London NHS Trust | 1 |
| Bayer | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| Intellia Therapeutics | 1 |
| Mayo Clinic | 1 |
| NHS Greater Glasgow and Clyde | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathies | 14 |
| Cardiomyopathy, Hypertrophic | 4 |
| Amyloidosis | 3 |
| Cardiomyopathy, Dilated | 3 |
| Heart Diseases | 3 |
| Heart Failure | 3 |
| Atrial Fibrillation | 2 |
| Glycogen Storage Disease Type IIb | 2 |
| Myocarditis | 2 |
| Alzheimer Disease | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.